Overview
Anjali Rohatgi is a Hematologist practicing medicine in Saint Louis, Missouri.
Dr. Rohatgi is highly rated in 6 conditions, according to our data. Her clinical expertise encompasses Primitive Neuroectodermal Tumor (PNET), Posterior Fossa Tumor, Metastatic Brain Tumor, and Lung Cancer.
She is actively involved in clinical research, co-authoring 12 peer reviewed articles.
Specialties
Licenses
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- EPO
- PPO
- INSURANCE PLAN
- MEDICARE MAPD
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
4500 Forest Park Ave, Saint Louis, MO 63108
150 Entrance Way, Saint Peters, MO 63376
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Office
Brad Kahl is a Hematologist practicing medicine in Saint Louis, Missouri. Dr. Kahl is highly rated in 28 conditions, according to our data. His clinical expertise encompasses Mantle Cell Lymphoma (MCL), Follicular Lymphoma, Non-Hodgkin Lymphoma, Bone Marrow Aspiration, and Splenectomy.
Office
Neha Mehta is a Hematologist practicing medicine in Saint Louis, Missouri. She has been practicing medicine for over 17 years. Dr. Mehta is highly rated in 23 conditions, according to our data. Her clinical expertise encompasses Peripheral T-Cell Lymphoma, T-Cell Lymphoma, Non-Hodgkin Lymphoma, Cutaneous T-Cell Lymphoma (CTCL), and Bone Marrow Aspiration.
Washington University
Geoffrey Uy is a Hematologist practicing medicine in Saint Louis, Missouri. Dr. Uy is highly rated in 24 conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Leukemia, Myelodysplastic Syndrome (MDS), Bone Marrow Transplant, and Bone Marrow Aspiration.
Frequently Asked Questions about Dr. Anjali Rohatgi
How do I make an appointment with Dr. Anjali Rohatgi?
You can book an appointment with Dr. Anjali Rohatgi by calling their office at 314-747-1171. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Anjali Rohatgi a top-rated expert for Primitive Neuroectodermal Tumor (PNET)?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Anjali Rohatgi is classified as an Advanced expert for Primitive Neuroectodermal Tumor (PNET), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Anjali Rohatgi specialize in?
While Dr. Anjali Rohatgi is a Hematology, they have specific expertise in Primitive Neuroectodermal Tumor (PNET), Posterior Fossa Tumor, and Metastatic Brain Tumor. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.
Does Dr. Anjali Rohatgi participate in research or clinical trials?
Yes. Dr. Anjali Rohatgi has published 12 articles and abstracts on conditions like Primitive Neuroectodermal Tumor (PNET). You can view a list of Dr. Anjali Rohatgi's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Anjali Rohatgi accept my insurance?
Dr. Anjali Rohatgi accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 314-747-1171 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Lung CancerDr. Rohatgi isAdvanced. Learn about Lung Cancer.
- Metastatic Brain TumorDr. Rohatgi isAdvanced. Learn about Metastatic Brain Tumor.
- Pleuropulmonary BlastomaDr. Rohatgi isAdvanced. Learn about Pleuropulmonary Blastoma.
- Posterior Fossa TumorDr. Rohatgi isAdvanced. Learn about Posterior Fossa Tumor.
- Primitive Neuroectodermal Tumor (PNET)
- Small Cell Lung Cancer (SCLC)Dr. Rohatgi isAdvanced. Learn about Small Cell Lung Cancer (SCLC).
- Experienced
- ALK-Positive Non-Small Cell Lung CancerDr. Rohatgi isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- EGFR Positive Lung CancerDr. Rohatgi isExperienced. Learn about EGFR Positive Lung Cancer.
- Large-Cell Lung CarcinomaDr. Rohatgi isExperienced. Learn about Large-Cell Lung Carcinoma.
- Lung AdenocarcinomaDr. Rohatgi isExperienced. Learn about Lung Adenocarcinoma.
- MelanomaDr. Rohatgi isExperienced. Learn about Melanoma.
- Non-Small Cell Lung Cancer (NSCLC)Dr. Rohatgi isExperienced. Learn about Non-Small Cell Lung Cancer (NSCLC).